Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2073 ARTÍCULOS , VIENDO DEL 961 AL 975

[Alzheimer's disease and epilepsy]

Haussmann R, Mayer T, Schrempf W, Donix M.

Nervenarzt. 2017 Sep;88(9):1003-1009. doi: 10.1007/s00115-017-0286-2.

Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease

Geifman N, Brinton RD, Kennedy RE, Schneider LS, Butte AJ.

Alzheimers Res Ther. 2017 Feb 17;9(1):10. doi: 10.1186/s13195-017-0237-y.

Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer's Disease Patients

Ketter N, Brashear HR, Bogert J, Di J, Miaux Y, Gass A, Purcell DD, Barkhof F, Arrighi HM.

J Alzheimers Dis. 2017;57(2):557-573. doi: 10.3233/JAD-160216.

Risk factors associated with the onset and progression of Alzheimer's disease: A systematic review of the evidence

Hersi M, Irvine B, Gupta P, Gomes J, Birkett N, Krewski D.

Neurotoxicology. 2017 Jul;61:143-187. doi: 10.1016/j.neuro.2017.03.006. Epub 2017 Mar 29.

Vitamin E for Alzheimer's dementia and mild cognitive impairment

Farina N, Llewellyn D, Isaac MGEKN, Tabet N.

Cochrane Database Syst Rev. 2017 Apr 18;4(4):CD002854. doi: 10.1002/14651858.CD002854.pub5.

Anosognosia and Its Relation to Psychiatric Symptoms in Early-Onset Alzheimer Disease

Yoon B, Shim YS, Hong YJ, Choi SH, Park HK, Park SA, Jeong JH, Yoon SJ, Yang DW.

J Geriatr Psychiatry Neurol. 2017 May;30(3):170-177. doi: 10.1177/0891988717700508.

Frailty in older adults with amnestic mild cognitive impairment as a result of Alzheimer's disease: A comparison of two models of frailty characterization

Cezar NOC, Izbicki R, Cardoso D, Almeida JG, Valiengo L, Camargo MVZ, Forlenza OV, Yassuda MS, Aprahamian I.

Geriatr Gerontol Int. 2017 Nov;17(11):2096-2102. doi: 10.1111/ggi.13028. Epub 2017 May 10.

Alzheimer's Disease in the Latino Community: Intersection of Genetics and Social Determinants of Health

Vega IE, Cabrera LY, Wygant CM, Velez-Ortiz D, Counts SE.

J Alzheimers Dis. 2017;58(4):979-992. doi: 10.3233/JAD-161261.

Challenging Assumptions About African American Participation in Alzheimer Disease Trials

Kennedy RE, Cutter GR, Wang G, Schneider LS.

Am J Geriatr Psychiatry. 2017 Oct;25(10):1150-1159. doi: 10.1016/j.jagp.2017.04.013. Epub 2017 Apr 25.

Body Mass Index and Risk of Alzheimer's Disease: A Mendelian Randomization Study of 399,536 Individuals

Nordestgaard LT, Tybjærg-Hansen A, Nordestgaard BG, Frikke-Schmidt R.

J Clin Endocrinol Metab. 2017 Jul 1;102(7):2310-2320. doi: 10.1210/jc.2017-00195.

Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review

Solfrizzi V, Custodero C, Lozupone M, Imbimbo BP, Valiani V, Agosti P, Schilardi A, D'Introno A, La Montagna M, Calvani M, Guerra V, Sardone R, Abbrescia DI, Bellomo A, Greco A, Daniele A, Seripa D, Logroscino G, Sabbá C, Panza F.

J Alzheimers Dis. 2017;59(3):815-849. doi: 10.3233/JAD-170248.

Mild cognitive impairment in type 2 diabetes mellitus and related risk factors: a review

Yuan XY, Wang XG.

Rev Neurosci. 2017 Oct 26;28(7):715-723. doi: 10.1515/revneuro-2017-0016.

Tracking Cognitive Decline in Amnestic Mild Cognitive Impairment and Early-Stage Alzheimer Dementia: Mini-Mental State Examination versus Neuropsychological Battery

Kim J, Na HK, Byun J, Shin J, Kim S, Lee BH, Na DL.

Dement Geriatr Cogn Disord. 2017;44(1-2):105-117. doi: 10.1159/000478520. Epub 2017 Aug 3.

Association between LRP1 C766T polymorphism and Alzheimer's disease susceptibility: a meta-analysis

Wang Y, Liu S, Wang J, Zhang J, Hua Y, Li H, Tan H, Kuai B, Wang B, Sheng S.

Sci Rep. 2017 Aug 16;7(1):8435. doi: 10.1038/s41598-017-08335-w.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias